Department of Emergency Medicine, Asahikawa Medical University, Asahikawa, Japan.
Emergency and Critical Care Center, Hokkaido University Hospital, Sapporo, Japan.
J Intensive Care Med. 2020 Dec;35(12):1389-1395. doi: 10.1177/0885066618823151. Epub 2019 Jan 13.
Currently, it remains controversial whether the Sepsis-3 definition provides the most appropriate criteria for clinical use. The purpose of this study was to compare between the Sepsis-2 and Sepsis-3 definitions using Japan's nationwide registry.
Data were obtained from a multicenter registry conducted at 42 intensive care units (ICUs) throughout Japan, in which patients received treatment for severe sepsis or septic shock between January 2011 and December 2013.
A total of 2797 patients diagnosed using the Sepsis-2 criteria were included in the present study. These patients were categorized into "Severe sepsis" (n = 1154) and "Sepsis-2 shock" (n = 1643) groups. Among the "Sepsis-2 shock" group, patients who did not meet the Sepsis-3 criteria for septic shock were categorized into the "Sepsis-2 shock-only" (n = 448, 27.3%) group, while patients who met the Sepsis-3 criteria for septic shock were categorized into "Sepsis-3 shock (n = 1195, 72.7%)" group. The ICU mortality in the "Sepsis-3 shock" group, "Sepsis-2 shock-only" group, and "Severe sepsis" group was 28.5%, 10.9%, and 14.1%, respectively. We observed no significant difference between the "Severe sepsis" and "Sepsis-2 shock-only" groups in terms of in-hospital survival ( = .098), while the "Sepsis-3 shock" group had the highest in-hospital mortality rate ( < .001). In a multivariate logistic regression analysis, liver insufficiency and immunocompromised status were independent prognostic factors in the "Sepsis-2 shock-only" group. In contrast, chronic heart disease and chronic hemodialysis were independent prognostic factors in the "Sepsis-3 shock" group.
The ICU mortality of the "Sepsis-2 shock-only" group was significantly low. Besides septic shock diagnosed by the Sepsis-3 definition selects patients with more severe cases of sepsis among the "Sepsis-2 shock" group.
目前,Sepsis-3 定义是否为临床应用提供了最合适的标准仍存在争议。本研究旨在使用日本全国登记处比较 Sepsis-2 和 Sepsis-3 定义。
数据来自于 2011 年 1 月至 2013 年 12 月期间在日本 42 家重症监护病房(ICU)进行的多中心登记处,其中患者接受严重脓毒症或感染性休克治疗。
本研究共纳入了根据 Sepsis-2 标准诊断的 2797 例患者。这些患者分为“严重脓毒症”(n = 1154)和“Sepsis-2 休克”(n = 1643)两组。在“Sepsis-2 休克”组中,未满足 Sepsis-3 感染性休克标准的患者被分为“Sepsis-2 休克仅”(n = 448,27.3%)组,而满足 Sepsis-3 感染性休克标准的患者被分为“Sepsis-3 休克”(n = 1195,72.7%)组。“Sepsis-3 休克”组、“Sepsis-2 休克仅”组和“严重脓毒症”组的 ICU 死亡率分别为 28.5%、10.9%和 14.1%。我们观察到“Sepsis-3 休克”组、“Sepsis-2 休克仅”组和“严重脓毒症”组之间的院内生存率无显著差异( =.098),而“Sepsis-3 休克”组的院内死亡率最高(<.001)。多变量逻辑回归分析显示,肝功能不全和免疫抑制状态是“Sepsis-2 休克仅”组的独立预后因素。相比之下,慢性心脏病和慢性血液透析是“Sepsis-3 休克”组的独立预后因素。
“Sepsis-2 休克仅”组的 ICU 死亡率显著较低。此外,Sepsis-3 定义诊断的感染性休克在“Sepsis-2 休克”组中选择了更严重脓毒症的患者。